Celcuity CELC
NASDAQ CELC
$94.65 -1.78 (-1.84%)
As of: Sep 4, 2026 · 12:51 PM EDT

Celcuity (CELC) Non Operating Income (2016 - 2026)

Celcuity's (CELC) quarterly Non Operating Income came in at -$1.8 million in Q4 2025, down 694.62% YoY from $298006.0 in Q4 2024, and down 85.55% on a QoQ basis from -$955000.0 in Q3 2025.

Analysis

Celcuity (CELC) Non Operating Income (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 9 years of Non Operating Income data on file, last reported at -$1.8 million in Q4 2025.

  • Quarterly Non Operating Income fell 694.62% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.8 million (down 425.94% YoY) and the FY2025 annual result came in at -$4.8 million, down 425.94% from the prior year.
  • Non Operating Income eased to -$1.8 million in Q4 2025, from -$955000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $881000.0 in Q1 2024 to a low of -$1.8 million in Q4 2025.
  • A 4-year average of -$368362.2 and a median of -$359799.0 in 2022 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2021 — Non Operating Income sank 7499.34% — and 2022, when it jumped 41.48%.
  • Tracing CELC's Non Operating Income over 4 years: stood at -$427460.0 in 2021, then surged by 41.48% to -$250166.0 in 2022, then climbed by 10.86% to -$223000.0 in 2024, then sank by 694.62% to -$1.8 million in 2025.
  • The last three Non Operating Income figures came in at -$1.8 million (Q4 2025), -$955000.0 (Q3 2025), and -$1.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -139.24 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - -51.63 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
10 Celcuity 5.19 Bn 5.19 Bn - -12.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.75 Mn
Dec 31, 2025 -1.77 Mn
Sep 30, 2025 -955,000.00
Jun 30, 2025 -1.26 Mn
Mar 31, 2025 -864,000.00
Dec 31, 2024 -223,000.00
Sep 30, 2024 268,000.00
Jun 30, 2024 562,000.00
Mar 31, 2024 881,000.00
Sep 30, 2022 -250,166.00
Jun 30, 2022 -359,799.00
Sep 30, 2021 -427,460.00
Jun 30, 2021 -389,384.00
Mar 31, 2021 101.00
Dec 31, 2020 443.00
Sep 30, 2020 5,777.00
Jun 30, 2020 11,952.00
Mar 31, 2020 63,818.00
Dec 31, 2019 88,739.00
Sep 30, 2019 107,061.00